EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antithrombotic Strategies With Left Ventricular Assist Devices

Maja Cikes, Melana Yuzefpolskaya, Finn Gustafsson, Mandeep R Mehra

Journal of Cardiac Failure · 2024

DOI: 10.1016/j.cardfail.2024.07.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiac Failure, 2024. Verfasst von Maja Cikes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Failure. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Abbott Laboratories.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term outcomes of patients with advanced heart failure treated with durable left ventricular assist devices (LVADs) have been augmented due to improved durability and hemocompatibility on the backbone of pump engineering enhancements. The incidence of hemocompatibility-related adverse events (pump thrombosis, stroke and nonsurgical bleeding events) are device specific and vary by type of engineered pump. A fully magnetically levitated rotor containing LVAD in concert with use of antithrombotic therapy has successfully overcome an increased risk of pump thrombosis and stroke-risk, albeit with only modest reduction in bleeding events. Modifications to antithrombotic strategies have focused on reduced-dose vitamin K antagonist use or use of direct oral anticoagulants with demonstration of safety and progress in reduction of mucosal bleeding episodes with elimination of antiplatelet agents. This review outlines the current landscape of advances in anticoagulation management in LVAD patients, highlighting the need for ongoing research and cautious application of emerging therapies and technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart FailureHumansFibrinolytic AgentsThrombosisAnticoagulants

Stichwörter der Autor:innen

Left ventricular assist devicesadvanced heart failureanticoagulation therapyantiplatelet therapyantithrombotic therapyhemocompatibility

Substanzen

Fibrinolytic AgentsAnticoagulants

Autor:innen und Institutionen

  • Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia.
  • Department of Cardiology, New York Presbyterian Hospital, Columbia University, New York, New York.
  • Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: mmehra@bwh.harvard.edu.

Förderung

  • Abbott Laboratories

Zitieren

APA

Cikes, M., Yuzefpolskaya, M., Gustafsson, F., & Mehra, M. R. (2024). Antithrombotic Strategies With Left Ventricular Assist Devices. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2024.07.024

Vancouver

Cikes M, Yuzefpolskaya M, Gustafsson F, Mehra MR. Antithrombotic Strategies With Left Ventricular Assist Devices. Journal of Cardiac Failure. 2024. doi:10.1016/j.cardfail.2024.07.024

BibTeX
@article{Cikes2024,
  author = {Cikes, Maja and Yuzefpolskaya, Melana and Gustafsson, Finn and Mehra, Mandeep R},
  title = {Antithrombotic Strategies With Left Ventricular Assist Devices},
  journal = {Journal of Cardiac Failure},
  year = {2024},
  doi = {10.1016/j.cardfail.2024.07.024}
}
Kostenlos starten →